|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Acacia Research - CombiMatrix Warrants (right to buy) | $ 0.55 | 05/04/2007 | P | 1,050,000 | 05/04/2007 | 05/04/2012 | Acacia Research - CombiMatrix Common Stock | 1,050,000 | (1) | 1,050,000 | D | ||||
Acacia Research - CombiMatrix Warrants (right to buy) | $ 0.55 | 05/04/2007 | P | 2,100,000 | 05/04/2007 | 05/04/2012 | Acacia Research - CombiMatrix Common Stock | 2,100,000 | (2) | 2,100,000 | I | See Footnote (3) |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
AKIN THOMAS B 500 NEWPORT CENTER DRIVE 7TH FLOOR NEWPORT BEACH, CA 92660 |
X |
Thomas B. Akin | 05/08/2007 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | The reported securites are included within 700,000 Acacia Research - CombiMatrix (CBMX) Units purchased by the reporting person for $0.738 per unit, for a total of $516,250. Each Unit consists of one share of CBMX common stock and 1.5 warrants to purchase 1,050,000 shares of CBMX common stock. |
(2) | The reported securites are included within 1,400,000 Acacia Research - CombiMatrix (CBMX) Units purchased by the reporting person for $0.738 per unit, for a total of $1,032,500. Each Unit consists of one share of CBMX common stock and 1.5 warrants to purchase 2,100,000 shares of CBMX common stock. |
(3) | Held by Talkot Fund, L.P. Mr. Akin serves as managing general partner of Talkot Fund, L.P. Mr. Akin disclaims beneficial ownership in the shares held by Talkot Fund, L.P. except to the extent of his pecuniary interest therein. |